INNOVATIL-04 CERVICAL CARCINOMA Trademark
Trademark Overview
On Thursday, February 28, 2019, a trademark application was filed for INNOVATIL-04 CERVICAL CARCINOMA with the United States Patent and Trademark Office. The USPTO has given the INNOVATIL-04 CERVICAL CARCINOMA trademark a serial number of 88321101. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 26, 2019. This trademark is owned by Iovance Biotherapeutics, Inc.. The INNOVATIL-04 CERVICAL CARCINOMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
conducting clinical trials for others for research and the treatment of cancer and oncological diseases; providing medical and scientific research information related to clinical trials for the treatment of cancer and oncological diseases; medical evaluation services, namely, providing drug therapies and treatment programs for the treatment of cancer and oncological diseases, and providing assessments of treatment programs
General Information
| Serial Number | 88321101 |
| Word Mark | INNOVATIL-04 CERVICAL CARCINOMA |
| Filing Date | Thursday, February 28, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, November 26, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | The color(s) green, blue and grey is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "CERVICAL CARCINOMA" |
| Description of Mark | The mark consists of the term INNOVATIL-04 and a design, with "innova" in green lower case letters and "TIL" in uppercase bold green letters and "-04" in blue, and the design comprised of green and blue bars and dots in seven lines; and with the wording "CERVICAL CARCINOMA" in all uppercase grey letters just below the "INNOVATIL-04" term. |
| Goods and Services | conducting clinical trials for others for research and the treatment of cancer and oncological diseases; providing medical and scientific research information related to clinical trials for the treatment of cancer and oncological diseases; medical evaluation services, namely, providing drug therapies and treatment programs for the treatment of cancer and oncological diseases, and providing assessments of treatment programs |
| Pseudo Mark | INNOVATIL-ZERO FOUR CERVICAL CARCINOMA |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Iovance Biotherapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Carlos, CA 94070 |
Trademark Events
| Event Date | Event Description |
| Tuesday, November 26, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, November 26, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, May 15, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 8, 2019 | ASSIGNED TO EXAMINER |
| Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, March 20, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, March 4, 2019 | NEW APPLICATION ENTERED IN TRAM |
